Malignancies and monoclonal gammopathy in Gaucher disease; a systematic review of the literature

British Journal of Haematology

Volumn 161, Issue 6, 2013, Pages 832-842

  Arends, Maarten ^a   Van Dussen, Laura ^a   Biegstraaten, Marieke ^a   Hollak, Carla E M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Cancer; Gaucher disease; Malignancy; Monoclonal gammopathy of undetermined significance; Multiple myeloma

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; AMYLOIDOSIS; ARTICLE; CANCER RISK; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; DISEASE ASSOCIATION; ENDOPLASMIC RETICULUM STRESS; GAUCHER DISEASE; HEMATOLOGIC MALIGNANCY; HODGKIN DISEASE; HUMAN; IMMUNE DYSREGULATION; INSULIN RESISTANCE; IRON METABOLISM; KIDNEY CARCINOMA; LEUKEMIA; LIVER CELL CARCINOMA; MONOCLONAL IMMUNOGLOBULINEMIA; MORTALITY; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; NEOPLASM; NONHODGKIN LYMPHOMA; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; SPLENECTOMY; SYSTEMATIC REVIEW;

GAUCHER DISEASE; HUMANS; NEOPLASMS; PARAPROTEINEMIAS; PREVALENCE; RISK;

EID: 84878496452     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12335     Document Type: Article

References (124)

1. Airo, R., Gabusi, G. & Guindani, M. (1993) Gaucher's disease associated with monoclonal gammapathy of undetermined significance: a case report. Haematologica, 78, 129-131.
2. Allen, M.J., Myer, B.J., Khokher, A.M., Rushton, N. & Cox, T.M. (1997) Pro-inflammatory cytokines and the pathogenesis of Gaucher's disease: increased release of interleukin-6 and interleukin-10. QJM: An International Journal of Medicine, 90, 19-25.
3. Amstutz, H.C. & Carey, E.J. (1966) Skeletal manifestations and treatment of Gaucher's disease. Review of twenty cases. The Journal of Bone and Joint Surgery; American volume, 48, 670-701.
4. Aubourg, A., Benboubker, L., Picon, L., Goupille, P. & Maillot, F. (2011) Successful autologous stem cell transplantation in Gaucher disease patient with multiple myeloma. American Journal of Hematology, 86, 529-530.
5. Balreira, A., Lacerda, L., Miranda, C.S. & Arosa, F.A. (2005) Evidence for a link between sphingolipid metabolism and expression of CD1d and MHC-class II: monocytes from Gaucher disease patients as a model. British Journal of Haematology, 129, 667-676.
6. Barton, N.W., Brady, R.O., Dambrosia, J.M., Di Bisceglie, A.M., Doppelt, S.H., Hill, S.C., Mankin, H.J., Murray, G.J., Parker, R.I., Argoff, C.E., Grewal, R.P. & Yu, K.-T. (1991) Replacement therapy for inherited enzyme deficiency-macrophage-targeted glucocerebrosidase for Gaucher's disease. The New England Journal of Medicine, 324, 1464-1470.
7. Benjamin, D., Joshua, H., Djaldetti, M., Hazaz, B. & Pinkhas, J. (1979) Nonsecretory IgD-kappa multiple myeloma in a patient with Gaucher's disease. Scandinavian Journal of Haematology, 22, 179-184.
8. Bertram, H.C., Eldibany, M., Padgett, J. & Dragon, L.H. (2003) Splenic lymphoma arising in a patient with Gaucher disease. A case report and review of the literature. Archives of Pathology & Laboratory Medicine, 127, e242-e245.
9. Beutler, E. (1977) Gaucher's disease in an asymptomatic 72-year-old. The Journal of the American Medical Association, 237, 2529.
10. Bohm, P., Kunz, W., Horny, H.P. & Einsele, H. (2001) Adult Gaucher disease in association with primary malignant bone tumors. Cancer, 91, 457-462.
11. Boot, R.G., Verhoek, M., de Fost, M., Hollak, C.E., Maas, M., Bleijlevens, B., van Breemen, M.J., van Meurs, M., Boven, L.A., Laman, J.D., Moran, M.T., Cox, T.M. & Aerts, J.M. (2004) Marked elevation of the chemokine CCL18/PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic intervention. Blood, 103, 33-39.
12. Boven, L.A., van Meurs, M., Boot, R.G., Mehta, A., Boon, L., Aerts, J.M. & Laman, J.D. (2004) Gaucher cells demonstrate a distinct macrophage phenotype and resemble alternatively activated macrophages. American Journal of Clinical Pathology, 122, 359-369.
13. Brady, K., Corash, L. & Bhargava, V. (1997) Multiple myeloma arising from monoclonal gammopathy of undetermined significance in a patient with Gaucher's disease. Archives of Pathology & Laboratory Medicine, 121, 1108-1111.
14. Brautbar, A., Elstein, D., Pines, G., Abrahamov, A. & Zimran, A. (2004) Effect of enzyme replacement therapy on gammopathies in Gaucher disease. Blood Cells Molecules & Diseases, 32, 214-217.
15. Breiden-Langen, C.M., Buchsel, R., Brambs, H.J., Oehlert, M. & Matern, S. (1991) Coincidence of Gaucher disease with primary hepatocellular carcinoma. Leber, Magen, Darm 126, 129-130.
16. Brody, J.D., Advani, R., Shin, L.K., Bingham, D.B. & Rosenberg, S.A. (2006) Splenic diffuse large B-cell lymphoma in a patient with type 1 Gaucher disease: diagnostic and therapeutic challenges. Annals of Hematology, 85, 817-820.
17. Bruckstein, A.H., Karanas, A. & Dire, J.J. (1980) Gaucher's disease associated with Hodgkin's disease. The American Journal of Medicine, 68, 610-613.
18. Burstein, Y., Rechavi, G., Rausen, A.R., Frisch, B. & Spirer, Z. (1985) Association of Gaucher's disease and lymphoid malignancy in 2 children. Scandinavian Journal of Haematology, 35, 445-447.
19. Burstein, Y., Zakuth, V., Rechavi, G. & Spirer, Z. (1987) Abnormalities of cellular immunity and natural killer cells in Gaucher's disease. Journal of Clinical & Laboratory Immunology, 23, 149-151.
20. Cajaiba, M.M. & Reyes-Mugica, M. (2009) Gaucher or pseudo-Gaucher? The challenge of several diseases colliding in a pediatric patient. Human Pathology, 40, 594-598.
21. Carreiro, J., Balwani, M., Grosskreutz, C., Isola, L., Malone, A., Scigliano, E. & Osman, K. (2008) A case report of secondary autograft failure due to Gaucher disease. American Journal of Hematology, 83, 937.
22. Castelli, R., Cassinerio, E., Iurlo, A., Zanella, A., Gianelli, U. & Cappellini, M.D. (2006) Unusual severe development of common B lymphoblastic leukemia in Gaucher disease type I. American Journal of Hematology, 81, 383-384.
23. Chang-Lo, M., Yam, L.T. & Rubenstone, A.I. (1967) Gaucher's disease. Review of the literature and report of twelve new cases. The American Journal of the Medical Sciences, 254, 303-315.
24. Chang-Lo, M., Yam, L.T., Rubenstone, A.I. & Schwartz, S.O. (1975) Gaucher's disease associated with chronic lymphocytic leukaemia, gout and carcinoma. The Journal of Pathology, 116, 203-207.
25. Cheung, W.Y., Greenberg, C.R., Bernstein, K., Schacter, B., Fourie, T. & Seftel, M.D. (2007) Type I Gaucher disease following chemotherapy for light chain multiple myeloma. Internal Medicine, 46, 1255-1258.
26. Cho, S.Y. & Sastre, M. (1976) Coexistence of Hodgkin's disease and Gaucher's disease. American Journal of Clinical Pathology, 65, 103-108.
27. Corbett, G.M., Darbyshire, P.J., Besley, G.T. & Parker, A.C. (1987) Adult Gaucher disease in association with acute leukaemia. Postgraduate Medical Journal, 63, 899-900.
28. Cox, T.M., Aerts, J.M., Andria, G., Beck, M., Belmatoug, N., Bembi, B., Chertkoff, R., Vom, D.S., Elstein, D., Erikson, A., Giralt, M., Heitner, R., Hollak, C., Hrebicek, M., Lewis, S., Mehta, A., Pastores, G.M., Rolfs, A., Miranda, M.C. & Zimran, A. (2003) The role of the iminosugar N-butyldeoxynojirimycin (miglustat) in the management of type I (non-neuronopathic) Gaucher disease: a position statement. Journal of Inherited Metabolic Disease, 26, 513-526.
29. Davis, M. & Dorfman, J. (1961) Gaucher's disease associated with a cerebral astrocytoma. A case report involving an adult. American Practitioner and Digest of Treatment, 12, 673-677.
30. Decaux, O., Ruelland, A. & Grosbois, B. (2007) Effect of treatment on biclonal gammopathy associated with Gaucher disease. Journal of Inherited Metabolic Disease, 30, 824.
31. Deibener, J., Kaminsky, P., Jacob, C., Dousset, B., Klein, M. & Duc, M. (1998) Enzyme replacement therapy decreases hypergammaglobulinemia in Gaucher's disease. Haematologica, 83, 479-480.
32. Dikman, S.H., Goldstein, M., Kahn, T., Leo, M.A. & Weinreb, N. (1978) Amyloidosis. An unusual complication of Gaucher's disease. Archives of Pathology & Laboratory Medicine, 102, 460-462.
33. Elad, S., Czerninski, R., Fischman, S., Keshet, N., Drucker, S., Davidovich, T. & Goldschmidt, N. (2010) Exceptional oral manifestations of amyloid light chain protein (AL) systemic amyloidosis. Amyloid 17, 27-31.
34. Elstein, D., Rosenmann, E., Reinus, C., Paz, J., Altarescu, G. & Zimran, A. (2003) Amyloidosis and gastric bleeding in a patient with Gaucher disease. Journal of Clinical Gastroenterology, 37, 234-237.
35. Erjavec, Z., Hollak, C.E. & de Vries, E.G. (1999) Hepatocellular carcinoma in a patient with Gaucher disease on enzyme supplementation therapy. Annals of Oncology, 10, 243-245.
36. Fleshner, P.R., Aufses, A.H. Jr, Grabowski, G.A. & Elias, R. (1991) A 27-year experience with splenectomy for Gaucher's disease. American Journal of Surgery, 161, 69-75.
37. de Fost, M., Vom Dahl, S., Weverling, G.J., Brill, N., Brett, S., Haussinger, D. & Hollak, C.E. (2006) Increased incidence of cancer in adult Gaucher disease in Western Europe. Blood Cells Molecules & Diseases, 36, 53-58.
38. de Fost, M., Out, T.A., de Wilde, F.A., Tjin, E.P., Pals, S.T., van Oers, M.H., Boot, R.G., Aerts, J.F., Maas, M., Vom Dahl, S. & Hollak, C.E. (2008) Immunoglobulin and free light chain abnormalities in Gaucher disease type I: data from an adult cohort of 63 patients and review of the literature. Annals of Hematology, 87, 439-449.
39. Fox, H., McCarthy, P., Andre-Schwartz, J., Shoenfeld, Y. & Miller, K.B. (1984) Gaucher's disease and chronic lymphocytic leukemia. Possible pathogenetic link between Gaucher's disease and B-cell proliferations? Cancer, 54, 312-314.
40. Gal, R., Gukovsky-Oren, S., Floru, S., Djaldetti, M. & Kessler, E. (1988) Sequential appearance of breast carcinoma, multiple myeloma and Gaucher's disease. Haematologica, 73, 63-65.
41. Garfinkel, D., Sidi, Y., Ben-Bassat, M., Salomon, F., Hazaz, B. & Pinkhas, J. (1982) Coexistence of Gaucher's disease and multiple myeloma. Archives of Internal Medicine, 142, 2229-2230.
42. Gelfand, M.I. & Griboff, S.I. (1961) Gaucher's disease and acute leukemia. Journal of the Mount Sinai Hospital, New York, 28, 278-282.
43. Godsland, I.F. (2010) Insulin resistance and hyperinsulinaemia in the development and progression of cancer. Clinical Science (London, England: 1979), 118, 315-332.
44. Goldfarb, A., Atlas, D.H. & Gaberman, P. (1950) Electrophoretic studies in Gaucher's disease. American Journal of Clinical Pathology, 20, 963-965.
45. Goodman, S. (1988) Nodular sclerosing Hodgkin's disease in association with Gaucher's disease. Clinical Radiology, 39, 326-327.
46. Grabowski, G.A. (2012) Gaucher disease and other storage disorders. Hematology/the Education Program of the American Society of Hematology, 2012, 13-18.
47. Grabowski, G.A., Barton, N.W., Pastores, G., Dambrosia, J.M., Banerjee, T.K., McKee, M.A., Parker, C., Schiffmann, R., Hill, S.C. & Brady, R.O. (1995) Enzyme therapy in type 1 Gaucher disease: comparative efficacy of mannose-terminated glucocerebrosidase from natural and recombinant sources. Annals of Internal Medicine, 122, 33-39.
48. Grabowski, G.A., Petsko, G.A. & Kolodny, E.H. (2010) Gaucher disease. In: The Online Metabolic and Molecular Bases of Inherited Disease (ed. by D. Valle, A.L. Beaudet, B. Vogelstein, K.W. Kinzler, S.E. Antonarakis & A. Ballabio ), 1-139. McGraw-Hill, Inc., New York, NY.
49. Greenberg, A.J., Rajkumar, S.V. & Vachon, C.M. (2012) Familial monoclonal gammopathy of undetermined significance and multiple myeloma: epidemiology, risk factors, and biological characteristics. Blood, 119, 5359-5366.
50. Groen, J. & Garrer, A.H. (1948) Adult Gaucher's disease, with special reference to the variations in its clinical course and the value of sternal puncture as an aid to its diagnosis. Blood, 3, 1221-1237.
51. Grosbois, B., Rose, C., Noel, E., Serratrice, C.R., Dobbelaere, D., Gressin, V., Cherin, P., Hartmann, A., Javier, R.M., Clerson, P., Hachulla, E. & Jaussaud, R. (2009) Gaucher disease and monoclonal gammopathy: a report of 17 cases and impact of therapy. Blood Cells Molecules & Diseases, 43, 138-139.
52. Hanash, S.M., Rucknagel, D.L., Heidelberger, K.P. & Radin, N.S. (1978) Primary amyloidosis associated with Gaucher's disease. Annals of Internal Medicine, 89, 639-641.
53. Haran, M.Z., Feldberg, E. & Berrebi, A. (2001) Incidental diagnosis of Gaucher's disease in an elderly patient with lymphoma. Leukemia & Lymphoma, 40, 445-446.
54. Harder, H., Eucker, J., Zang, C., Possinger, K., Muller-Hocker, J., Beutler, E. & Petrides, P.E. (2000) Coincidence of Gaucher's disease due to a 1226G/1448C mutation and of an immunoglobulin G lambda multiple myeloma with Bence-Jones proteinuria. Annals of Hematology, 79, 640-643.
55. Hawkesford, M.P., Bowey, A.J., Rao, J. & Meara, N.J. (2011) Synchronous presentation of Gaucher disease and solitary plasmacytoma with progression to multiple myeloma. ScottishMedical Journal, 56, 236.
56. Higgins, J. & Green, S. (2011) Cochrane handbook for systematic reviews of interventionsVersion 5.1.0. 1-3-2011.
57. Hollak, C.E., Evers, L., Aerts, J.M. & van Oers, M.H. (1997) Elevated levels of M-CSF, sCD14 and IL8 in type 1 Gaucher disease. Blood Cells Molecules & Diseases, 23, 201-212.
58. Hrebicek, M., Zeman, J., Musilova, J., Hodanova, K., Renkema, G.H., Veprekova, L., Ledvinova, J., Hrebicek, D., Sokolova, J., Aerts, J.M. & Elleder, M. (1996) A case of type I Gaucher disease with cardiopulmonary amyloidosis and chitotriosidase deficiency. Virchows Archiv, 429, 305-309.
59. Hughes, D.A., Ginsberg, L., Baker, R., Goodwin, S., Milligan, A., Richfield, L. & Mehta, A.B. (2007) Effective treatment of an elderly patient with Gaucher's disease and Parkinsonism: a case report of 24 months' oral substrate reduction therapy with miglustat. Parkinsonism & Related Disorders, 13, 365-368.
60. Jurecka, A., Gregorek, H., Kleinotiene, G., Czartoryska, B. & Tylki-Szymanska, A. (2010) Gaucher disease and dysgammaglobulinemia: a report of 61 patients, including 18 with GD type III. Blood Cells Molecules & Diseases, 46, 85-87.
61. Kaloterakis, A., Filiotou, A., Koskinas, J., Raptis, I., Zouboulis, C., Michelakakis, H. & Hadziyannis, S. (1999) Systemic AL amyloidosis in Gaucher disease. A case report and review of the literature. Journal of Internal Medicine, 246, 587-590.
62. Katzen, B.T. (1975) Positive lymphangiography in gaucher's disease. Report of a case. Radiology, 115, 85-86.
63. Kaufman, S., Rozenfeld, V., Yona, R. & Varon, M. (1986) Gaucher's disease associated with chronic lymphocytic leukaemia. Clinical & Laboratory Haematology, 8, 321-324.
64. Kenan, S., Abdelwahab, I.F., Hermann, G., Klein, M. & Pastores, G. (1996) Osteoblastoma of the humerus associated with type-I Gaucher's disease. A case report. The Journal of Bone and Joint Surgery; British volume, 78, 702-705.
65. Kojiro, M., Kage, M., Abe, H., Imamura, M., Shiraishi, K. & Mizoguchi, M. (1983) Association of dysgerminoma and gaucher's disease. Cancer, 51, 712-715.
66. Kolodny, E.H., Ullman, M.D., Mankin, H.J., Raghavan, S.S., Topol, J. & Sullivan, J.L. (1982) Phenotypic manifestations of Gaucher disease: clinical features in 48 biochemically verified type 1 patients and comment on type 2 patients. Progress in Clinical and Biological Research, 95, 33-65.
67. Krause, J.R., Bures, C. & Lee, R.E. (1979) Acute leukaemia and Gaucher's disease. Scandinavian Journal of Haematology, 23, 115-118.
68. Krishnan, B., Ganeshaguru, K., Baker, R., Richfield, L. & Mehta, A.B. (2003) Multidrug resistance and myelomonocytic leukaemia in gaucher's disease. Haematologica, 88, ECR02.
69. Kyle, R.A., Therneau, T.M., Rajkumar, S.V., Offord, J.R., Larson, D.R., Plevak, M.F. & Melton, L.J. III (2002) A long-term study of prognosis in monoclonal gammopathy of undetermined significance. The New England Journal of Medicine, 346, 564-569.
70. Landgren, O., Turesson, I., Gridley, G. & Caporaso, N.E. (2007) Risk of malignant disease among 1525 adult male US Veterans with Gaucher disease. Archives of Internal Medicine, 167, 1189-1194.
71. Langeveld, M., Ghauharali, K.J., Sauerwein, H.P., Ackermans, M.T., Groener, J.E., Hollak, C.E., Aerts, J.M. & Serlie, M.J. (2008) Type I Gaucher disease, a glycosphingolipid storage disorder, is associated with insulin resistance. The Journal of Clinical Endocrinology and Metabolism, 93, 845-851.
72. Lee, R.E. (1982) The pathology of Gaucher disease. Progress in Clinical and Biological Research, 95, 177-217.
73. Leibovitz-BenGershon, Z., Rosenthal, J. & Shinar, E. (1982) A study of acid beta-glucosidase in a patient with Gaucher disease and leukemia. Progress in Clinical and Biological Research, 95, 481-491.
74. Leone, J.P. & Dudek, A.Z. (2008) Enzyme replacement therapy for Gaucher's disease in patient treated for non-small cell lung cancer. Anticancer Research, 28, 3937-3939.
75. Lieblich, M., Altarescu, G., Zimran, A. & Elstein, D. (2011) Vitamin D Receptor (VDR) polymorphic variants in patients with cancer and Gaucher disease. Blood Cells Molecules & Diseases, 46, 92-94.
76. Liel, Y., Hausmann, M.J. & Mozes, M. (1991) Case report: serendipitous Gaucher's disease presenting as elevated erythrocyte sedimentation rate due to monoclonal gammopathy. The American Journal of the Medical Sciences, 301, 393-394.
77. Liu, J., Halene, S., Yang, M., Iqbal, J., Yang, R., Mehal, W.Z., Chuang, W.L., Jain, D., Yuen, T., Sun, L., Zaidi, M. & Mistry, P.K. (2012) Gaucher disease gene GBA functions in immune regulation. Proceedings of the National Academy of Sciences of the United States of America, 109, 10018-10023.
78. Lo, S.M., Stein, P., Mullaly, S., Bar, M., Jain, D., Pastores, G.M. & Mistry, P.K. (2010) Expanding spectrum of the association between Type 1 Gaucher disease and cancers: a series of patients with up to 3 sequential cancers of multiple types-correlation with genotype and phenotype. American Journal of Hematology., 85, 340-345.
79. Lo, S.M., Choi, M., Liu, J., Jain, D., Boot, R.G., Kallemeijn, W.W., Aerts, J.M., Pashankar, F., Kupfer, G.M., Mane, S., Lifton, R.P. & Mistry, P.K. (2012) Phenotypic diversity in type 1 Gaucher disease: discovering the genetic basis of Gaucher disease/hematological malignancy phenotype by individual genome analysis. Blood, 119, 4731-4740.
80. Lyons, J.C., Scheithauer, B.W. & Ginsburg, W.W. (1982) Gaucher's disease and glioblastoma multiforme in two siblings: a clinicopathologic study. Journal of Neuropathology and Experimental Neurology, 41, 45-53.
81. MacDonald, M., McCathie, M., Faed, M.J., Pringle, R., Goodall, H.B., Beck, J.S., Tudhope, G.R., Mitchell, P.E., Wood, A.J., Guthrie, W. & Shaw, D. (1975) Proceedings: Gaucher's disease with biclonal gammopathy. Journal of Clinical Pathology, 28, 757.
82. Machaczka, M., Lerner, R., Klimkowska, M. & Hagglund, H. (2009) Treatment of multiple myeloma in patients with Gaucher disease. American Journal of Hematology, 84, 694-696.
83. Manz, M., Riessen, R., Poll, L., Dohmen, B., Kaiserling, E., Kruck, W., Laniado, M., Kanz, L. & Denzlinger, C. (2001) High-grade lymphoma mimicking bone crisis in Gaucher's disease. British Journal of Haematology, 113, 191-193.
84. Marie, J.P., Tulliez, M., Tricottet-Paczinski, V., Reynes, M. & Diebold, J. (1982) Gaucher's disease with monoclonal gammopathy. Significance of splenic plasmacytosis. Scandinavian Journal of Haematology, 28, 54-58.
85. Mark, T., Dominguez, C. & Rywlin, A.M. (1982) Gaucher's disease associated with chronic lymphocytic leukemia. Southern Medical Journal, 75, 361-363.
86. Marsh, R.D., Killeen, R.B. Jr & Agaliotis, D. (1993) Gaucher's disease associated with chronic lymphocytic leukemia. Southern Medical Journal, 86, 473-475.
87. Marti, G.E., Ryan, E.T., Papadopoulos, N.M., Filling-Katz, M., Barton, N., Fleischer, T.A., Rick, M. & Gralnick, H.R. (1988) Polyclonal B-cell lymphocytosis and hypergammaglobulinemia in patients with Gaucher disease. American Journal of Hematology, 29, 189-194.
88. Mateja, F., Maly, J., Tichy, M. & Langr, F.. (2000) [Uncommon combination of multiple myeloma in three patients]. Vnitrní Lékarství 46, 413-417. (abstract)
89. Miller, W., Lamon, J., Tavasolli, M., Longmire, R. & Beutler, E. (1982) Multiple Myeloma Complicating Gaucher's Disease. The Western Journal of Medicine, 136, 122-128.
90. Mistry, P.K., Liu, J., Yang, M., Nottoli, T., McGrath, J., Jain, D., Zhang, K., Keutzer, J., Chuang, W.L., Mehal, W.Z., Zhao, H., Lin, A., Mane, S., Liu, X., Peng, Y.Z., Li, J.H., Agrawal, M., Zhu, L.L., Blair, H.C., Robinson, L.J., Iqbal, J., Sun, L. & Zaidi, M. (2010) Glucocerebrosidase gene-deficient mouse recapitulates Gaucher disease displaying cellular and molecular dysregulation beyond the macrophage. Proceedings of the National Academy of Sciences of the United States of America, 107, 19473-19478.
91. Morgan, M.A., Hoffbrand, A.V., Laulicht, M., Luck, W. & Knowles, S. (1983) Serum ferritin concentration in Gaucher's disease. British Medical Journal (Clinical Research Ed.), 286, 1864.
92. Pastores, G.M., Weinreb, N.J., Aerts, H., Andria, G., Cox, T.M., Giralt, M., Grabowski, G.A., Mistry, P.K. & Tylki-Szymanska, A. (2004) Therapeutic goals in the treatment of Gaucher disease. Seminars in Hematology, 41, 4-14.
93. Paulson, J.A., Marti, G.E., Fink, J.K., Sato, N., Schoen, M. & Karcher, D.S. (1989) Richter's transformation of lymphoma complicating Gaucher's disease. Hematologic Pathology, 3, 91-96.
94. Perales, M., Cervantes, F., Cobo, F. & Montserrat, E. (1998) Non-Hodgkin's lymphoma associated with Gaucher's disease. Leukemia & Lymphoma, 31, 609-612.
95. Petrides, P.E., le Coutre, P., Muller-Hocker, J., Magin, E., Harzer, K., Demina, A. & Beutler, E. (1998) Coincidence of Gaucher's disease due to a private mutation and Ph' positive chronic myeloid leukemia. American Journal of Hematology, 59, 87-90.
96. Pinkhas, J., Djaldetti, M. & Yaron, M. (1965) Coincidence of multiple myeloma with Gaucher's disease. Israel Journal of Medical Sciences, 1, 537-540.
97. Pins, M.R., Mankin, H.J., Xavier, R.J., Rosenthal, D.I., Dickersin, G.R. & Rosenberg, A.E. (1995) Malignant epithelioid hemangioendothelioma of the tibia associated with a bone infarct in a patient who had Gaucher disease. A case report. The Journal of Bone and Joint Surgery; American volume, 77, 777-781.
98. Pratt, P.W., Kochwa, S. & Estren, S. (1968) Immunoglobulin abnormalities in Gaucher's disease. Report of 16 cases. Blood, 31, 633-640.
99. Ranade, A., Selegean, S., Sandhu, G., Ghali, V. & Shah, V.P. (2010) Acute lymphoblastic leukemia in a patient with type 1 Gaucher disease developing 1 year after discontinuation of enzyme replacement therapy. American Journal of Hematology, 85, 908-909.
100. Ron, I. & Horowitz, M. (2005) ER retention and degradation as the molecular basis underlying Gaucher disease heterogeneity. Human Molecular Genetics, 14, 2387-2398.
101. Rosenbloom, B.E., Weinreb, N.J., Zimran, A., Kacena, K.A., Charrow, J. & Ward, E. (2005) Gaucher disease and cancer incidence: a study from the Gaucher registry. Blood, 105, 4569-4572.
102. Ruestow, P.C., Levinson, D.J., Catchatourian, R., Sreekanth, S., Cohen, H. & Rosenfeld, S. (1980) Coexistence of IgA myeloma and Gaucher's disease. Archives of Internal Medicine, 140, 1115-1116.
103. Sanchez, R., Etzell, J., Kim, G., Packman, S., Fairley, C. & Goldsby, R. (2005) Pediatric malignancies. Case 2. Peripheral T-cell lymphoma in an adolescent with unsuspected Gaucher disease. Journal of Clinical Oncology, 23, 4792-4793.
104. Selby, J.V. & Friedman, G.D. (1988) Epidemiologic evidence of an association between body iron stores and risk of cancer. International Journal of Cancer, 41, 677-682.
105. Sharer, L.R., Barondess, J.A., Silver, R.T. & Gray, G.F. (1974) Association of Hodgkin disease and Gaucher disease. Archives of Pathology, 98, 376-378.
106. Shinar, E., Gershon, Z.L., Leiserowitz, R., Matzner, Y., Yatziv, S. & Polliack, A. (1982) Coexistence of Gaucher Disease and Philadelphia positive chronic granulocytic leukemia. American Journal of Hematology, 12, 199-202.
107. Shiran, A., Brenner, B., Laor, A. & Tatarsky, I. (1993) Increased risk of cancer in patients with Gaucher disease. Cancer, 72, 219-224.
108. Shoenfeld, Y., Gallant, L.A., Shaklai, M., Livni, E., Djaldetti, M. & Pinkhas, J. (1982) Gaucher's disease: a disease with chronic stimulation of the immune system. Archives of Pathology & Laboratory Medicine, 106, 388-391.
109. Shvidel, L., Hurwitz, N., Shtalrid, M., Zur, S., Oliver, O. & Berrebi, A. (1995) Complex IgA gammopathy in Gaucher's disease. Leukemia & Lymphoma, 20, 165-168.
110. Shvidel, L., Sigler, E., Shtalrid, M., Feldberg, E. & Berrebi, A. (2007) Parotid gland involvement, the presenting sign of high grade non-Hodgkin lymphoma in two patients with Gaucher disease and sicca syndrome. Journal of Inherited Metabolic Disease, 30, 825.
111. Stevens, R.G., Jones, D.Y., Micozzi, M.S. & Taylor, P.R. (1988) Body iron stores and the risk of cancer. The New England Journal of Medicine, 319, 1047-1052.
112. Symeonidis, A., Liga, M., Triantafyllou, E., Kouraklis, A., Tiniakou, M., Karakantza, M., Spyridonidis, A. & Zoumbos, N. (2011) Successful mobilization with plerixafor and autologous hematopoietic SCT in a patient with refractory Hodgkin's lymphoma and Gaucher disease. Bone Marrow Transplantation, 46, 1161-1162.
113. Taddei, T.H., Kacena, K.A., Yang, M., Yang, R., Malhotra, A., Boxer, M., Aleck, K.A., Rennert, G., Pastores, G.M. & Mistry, P.K. (2009) The underrecognized progressive nature of N370S Gaucher disease and assessment of cancer risk in 403 patients. American Journal of Hematology, 84, 208-214.
114. Tsung, S.H. & Cotes, E. (1977) Coexistence of bronchogenic carcinoma and Gaucher disease. Archives of Pathology & Laboratory Medicine, 101, 56.
115. Turesson, I. & Rausing, A. (1975) Gaucher's disease and benign monoclonal gammapathy. A case report with immunofluorescence study of bone marrow and spleen. Acta Medica Scandinavica, 197, 507-512.
116. Wang, P., Kang, D., Cao, W., Wang, Y. & Liu, Z. (2012) Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta-analysis. Diabetes/Metabolism Research and Reviews, 28, 109-122.
117. Webb, B.D., Weinreb, N.J., Botti, A.C., Kirmse, B.M. & Balwani, M. (2011) JAK2V617F mutation and myeloproliferative malignancy in a patient with Type 1 Gaucher disease. Blood Cells Molecules & Diseases, 46, 103-104.
118. Weinreb, N., Barbouth, D., Adkins, C. & Lee, R.E. (2012) Causes of Death (COD) in 184 Patients with Type 1 Gaucher Disease (GD1) from the United States Who Were Never Treated with Enzyme Replacement Therapy (ERT). (Abstract, WORLD symposium) Molecular Genetics and Metabolism, 105.2, S64.
119. Wine, E., Yaniv, I. & Cohen, I.J. (2007) Hyperimmunoglobulinemia in pediatric-onset type 1 Gaucher disease and effects of enzyme replacement therapy. Journal of Pediatric Hematology/Oncology, 29, 451-457.
120. Xu, R., Mistry, P., McKenna, G., Emre, S., Schiano, T., Bu-Ghanim, M., Levi, G. & Fiel, M.I. (2005) Hepatocellular carcinoma in type 1 Gaucher disease: a case report with review of the literature. Seminars in Liver Disease, 25, 226-229.
121. Zimran, A., Elstein, D., Levy-Lahad, E., Zevin, S., Hadas-Halpern, I., Bar-Ziv, Y., Foldes, J., Schwartz, A.J. & Abrahamov, A. (1995) Replacement therapy with imiglucerase for type 1 Gaucher's disease. Lancet, 345, 1479-1480.
122. Zimran, A., Liphshitz, I., Barchana, M., Abrahamov, A. & Elstein, D. (2005) Incidence of malignancies among patients with type I Gaucher disease from a single referral clinic. Blood Cells Molecules & Diseases, 34, 197-200.
123. Zimran, A., Ilan, Y. & Elstein, D. (2009) Enzyme replacement therapy for mild patients with Gaucher disease. American Journal of Hematology, 84, 202-204.
124. Zver, S., Bracko, M. & Andoljsek, D. (2010) Primary bone angiosarcoma in a patient with Gaucher disease. International Journal of Hematology, 92, 374-377.